Tanenberg RJ - Search Results

1

Endocrinologists' Opinions of Diabetology as a Primary Care Subspecialty.

Healy AM, Shubrook JH, Schwartz FL, Cummings DM, Drake AJ 3rd, Tanenberg RJ. Healy AM, et al. Among authors: tanenberg rj. Clin Diabetes. 2018 Apr;36(2):168-173. doi: 10.2337/cd17-0097. Clin Diabetes. 2018. PMID: 29686456 Free PMC article.

2

The Time Is Now: Diabetes Fellowships in the United States.

Sadhu AR, Healy AM, Patil SP, Cummings DM, Shubrook JH, Tanenberg RJ. Sadhu AR, et al. Among authors: tanenberg rj. Curr Diab Rep. 2017 Sep 23;17(11):108. doi: 10.1007/s11892-017-0936-6. Curr Diab Rep. 2017. PMID: 28942533 Review.

3

Diabetes Fellowship in Primary Care: A Survey of Graduates.

Healy AM, Tanenberg RJ, Schwartz FL, Shubrook JH. Healy AM, et al. Among authors: tanenberg rj. J Am Osteopath Assoc. 2018 Aug 1;118(8):538-543. doi: 10.7556/jaoa.2018.122. J Am Osteopath Assoc. 2018. PMID: 30073337 Free article.

4

Primary care fellowship in diabetes: an innovative program in postgraduate diabetes education.

Tanenberg RJ, Cummings DM, Dreyfus KS, Newton CA, Drake AJ 3rd, Lewis MJ. Tanenberg RJ, et al. Teach Learn Med. 2009 Oct;21(4):334-43. doi: 10.1080/10401330903228703. Teach Learn Med. 2009. PMID: 20183361

5

The efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with Type 2 diabetes: A systematic review and meta-analysis.

Mishriky BM, Cummings DM, Tanenberg RJ. Mishriky BM, et al. Among authors: tanenberg rj. Diabetes Res Clin Pract. 2015 Aug;109(2):378-88. doi: 10.1016/j.diabres.2015.05.025. Epub 2015 May 14. Diabetes Res Clin Pract. 2015. PMID: 26059071 Review.

6

Case report of acute necrotizing pancreatitis associated with combination treatment of sitagliptin and exenatide.

Iyer SN, Drake AJ 3rd, West RL, Mendez CE, Tanenberg RJ. Iyer SN, et al. Among authors: tanenberg rj. Endocr Pract. 2012 Jan-Feb;18(1):e10-3. doi: 10.4158/EP11264.CR. Endocr Pract. 2012. PMID: 22068258

7

Re-examining insulin compared to non-insulin therapies for type 2 diabetes: when in the disease trajectory is insulin preferable?

Mishriky BM, Cummings DM, Tanenberg R, Pories WJ. Mishriky BM, et al. Postgrad Med. 2018 Nov;130(8):653-659. doi: 10.1080/00325481.2018.1533381. Epub 2018 Oct 19. Postgrad Med. 2018. PMID: 30301398 Review.

8

Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system.

Tanenberg RJ, Newton CA, Drake AJ. Tanenberg RJ, et al. Endocr Pract. 2010 Mar-Apr;16(2):244-8. doi: 10.4158/EP09260.CR. Endocr Pract. 2010. PMID: 19833577

9

Comparing SGLT-2 inhibitors to DPP-4 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes: A systematic review and meta-analysis.

Mishriky BM, Tanenberg RJ, Sewell KA, Cummings DM. Mishriky BM, et al. Among authors: tanenberg rj. Diabetes Metab. 2018 Mar;44(2):112-120. doi: 10.1016/j.diabet.2018.01.017. Epub 2018 Feb 7. Diabetes Metab. 2018. PMID: 29477373 Review.

10

Comparing once-weekly semaglutide to incretin-based therapies in patients with type 2 diabetes: a systematic review and meta-analysis.

Mishriky BM, Cummings DM, Powell JR, Sewell KA, Tanenberg RJ. Mishriky BM, et al. Among authors: tanenberg rj. Diabetes Metab. 2019 Apr;45(2):102-109. doi: 10.1016/j.diabet.2018.09.002. Epub 2018 Sep 20. Diabetes Metab. 2019. PMID: 30243806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters